Theralink Technologies, Inc.
THER
$0.0001
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 47.75% | 225.12% | 363.34% | -366.58% | -2,310.65% |
| Total Depreciation and Amortization | -8.32% | 8.90% | 7.85% | 13.87% | 6.09% |
| Total Amortization of Deferred Charges | 88.26% | 1,852.05% | 1,941.46% | 2,318.08% | 1,641.96% |
| Total Other Non-Cash Items | -57.06% | -385.02% | -88,013.71% | 13,142.04% | 518,388.89% |
| Change in Net Operating Assets | 166.45% | 259.10% | 556.62% | -9.94% | 423.30% |
| Cash from Operations | 45.80% | -61.89% | 54.13% | -31.45% | -18.83% |
| Capital Expenditure | -- | -258.06% | 100.00% | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -258.06% | 100.00% | 100.00% | -- |
| Total Debt Issued | -- | 122.69% | -60.43% | -41.95% | 46.10% |
| Total Debt Repaid | 91.80% | -2,004.80% | -13.22% | -13.68% | 17.66% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.43% | 112.16% | -59.36% | -39.90% | 58.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -232.05% | 262.84% | 43.25% | -2,940.00% | 631.55% |